News from the FDA/CDC
News from the FDA/CDC
FDA OKs first condom for anal sex
Though the CDC has long encouraged the use of a condom during anal intercourse, the FDA had not until now deemed this practice safe.
News from the FDA/CDC
Immunocompromised patients should receive fourth COVID shot: CDC
The CDC contacted pharmacies on Jan. 26 to reinforce the message that people with moderate to severe immune suppression should receive a fourth...
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for psoriatic arthritis
The approval is the second indication for the anti–interleukin-23 monoclonal antibody after clearance for plaque psoriasis was granted in 2019.
Latest News
Prior COVID infection more protective than vaccination during Delta surge: U.S. study
“The evidence in this report does not change our vaccination recommendations,” said Dr. Ben Silk of the CDC.
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”
News from the FDA/CDC
CDC to update mask recommendations as Omicron spreads
“The best mask that you wear is the one you will wear and the one you can keep on all day long,” said Dr. Rochelle Walensky.
News from the FDA/CDC
COVID-19–positive or exposed? What to do next
News from the FDA/CDC
COVID-19 antigen tests may be less sensitive to Omicron: FDA
News from the FDA/CDC
FDA gives nod to tralokinumab for adults with moderate to severe AD
The drug is expected to be available by February 2022.
News from the FDA/CDC
CDC cuts isolation time for COVID-affected Americans to 5 days
News from the FDA/CDC
U.S. mulls reducing COVID quarantine time amid Omicron surge